Thousands spared strokes thanks to new NHS drug agreements
More than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new agreements to expand life-saving blood thinning drugs, chief executive Amanda Pritchard recently (16 November 2021) announced.
The NHS will now dramatically scale up the use of direct oral anticoagulants (DOACs) with as many as 610,000 more patients set to benefit over the next three years.
The drugs prevent strokes by treating and preventing blood clots in patients with atrial fibrillation (AF), a condition that causes an irregular and often abnormally fast heart rate.
The new framework agreement means their use will be expanded in line with the NHS Long Term Plan commitment to tackle strokes and other cardiovascular disease.
Speaking at NHS Providers conference, NHS Chief Executive Amanda Pritchard recently said:
“The agreements struck by NHS England will save thousands of lives and prevent many more people suffering the debilitating effects of strokes by making this treatment available to hundreds of thousands more patients.
“The health service now has a proven track record of striking deals with manufacturers to ensure patients in England get cutting-edge care at a price which offers best value for taxpayers.
“As we continue to emerge from the pandemic, tackle the backlogs of care which have been created and maintain momentum in the NHS COVID vaccination programme, we are also determined to keep delivering more innovation and greater efficiency in patients’ care.”
As well as expanding the use of direct oral anticoagulants NHSX is also using cutting edge technology to diagnose those with potentially fatal heart conditions, the NHS chief told the NHS Providers conference.
In a pilot, more than 5,000 people have been given wearable patches that use AI technology to analyse their heart rate, diagnosing potentially fatal conditions.
The technology provides clinicians with all the information they need to make a quick diagnosis and start treatment without the need for patients to undergo lots of tests and hospital visits.
The agreement on DOACs comes after NICE recommended the drugs as being more effective for the prevention of AF-related stroke than other anticoagulants.
NHS England then initiated a national procurement deal on DOACs, with the aim of making expanding access more affordable and saving money for both the health service and the taxpayer from the reduction in strokes.
The previous standard of anticoagulation treatment involved people needing to regularly attend their GP surgery or hospital for frequent monitoring. But treatment with a DOAC often only requires people to attend an annual review of their medicines.
NHS England’s new agreement will make DOACs more affordable, allowing the local NHS to provide them to 610,000 more patients. Uptake of DOAC treatment at this level will help to prevent an estimated 21,700 stokes and save the lives of 5,400 patients from a fatal outcome over the next three years.
Up to £40 million investment will also be made in ‘Detect, Protect and Perfect’ pathway initiatives which will also help identify people with AF and move them onto effective and appropriate treatment.
NHS England national specialty adviser for cardiovascular disease prevention Helen Williams recently said:
“The new agreement for these drugs is good news for the estimated 1.5 million people in England with atrial fibrillation, which is an irregular heart rhythm that causes one in five strokes.
“Not only is stroke one of the biggest killers in our country, but it leads to life-changing and often devastating long-term harm for many others, so by ensuring these drugs are made available for all people with AF who are at risk of stroke, the NHS will not only prevent serious harm to the people affected, but avoid the need for aftercare which puts additional pressure on the health service.
“Tackling heart disease and stroke is a top priority in the NHS Long Term Plan, which will save thousands of lives by better diagnosis and treatment for people with killer conditions.”
There are four different DOACs licensed to treat AF, which have all been recommended by NICE, while warfarin will still be used for some patients where appropriate.
A patient’s clinician will determine the most effective and appropriate treatment for a patient based on their clinical needs.
This commercial agreement for DOACs, that will go live from 1 January 2022, builds on NHS England’s approach to Hepatitis C elimination which saw an unique agreement with the pharmaceutical industry to support wider use of hepatitis C treatments, targeting patients not already receiving treatment.
Latest News from
NHS cancer checks at record high with quarter of a million in one month21/01/2022 09:15:00
Record numbers of people are coming forward for cancer tests, with almost a quarter of a million referrals in one month according to the latest data, the NHS said yesterday.
New plans to boost veterans employment launched19/01/2022 14:24:00
Veterans’ Strategy Action Plan launches, including more than 60 commitments to help veterans with employment and healthcare
NHS urges people to ‘grab a jab’ during week of walk-ins18/01/2022 11:15:00
People are being urged to Grab A Jab this week with a record number of walk-in sites available across the country, the NHS said today.
NHS to rollout boosters to most at risk 12 to 15 year-olds17/01/2022 16:20:00
The NHS has today (Monday) started to roll out booster vaccines to children aged 12 to 15 years old who are most at risk from coronavirus.
NHS launches landmark mental health campaign with ‘Help!’ from The Beatles17/01/2022 12:25:00
Today, the NHS will launch a new landmark campaign using the iconic Beatles song ‘Help!” to get the nation taking better care of their mental health.
Record number of NHS ambulance call outs for life-threatening conditions in December, despite jump in Omicron absences13/01/2022 16:33:00
NHS staff dealt with the highest ever number of life-threatening ambulance call outs last month, new figures show today.
More than 1.2 million vaccine appointments available this week12/01/2022 16:05:00
Over 1.2 million booster jab appointments are still up for grabs this week as the NHS COVID-19 vaccination programme continues at pace to protect the country against the virus.